These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3095497)

  • 1. The interactions between macrophages and developmental stages of Schistosoma mansoni: effect of macrophage function modulators on the viability of S. mansoni in vivo and in vitro.
    Malkin R; Flescher E; Lengy J; Keisari Y
    J Biol Response Mod; 1986 Oct; 5(5):470-80. PubMed ID: 3095497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection.
    James SL; Skamene E; Meltzer MS
    J Immunol; 1983 Aug; 131(2):948-53. PubMed ID: 6863937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the interactions between macrophages and developmental stages of Schistosoma mansoni: the cytotoxic mechanisms involved in macrophage-mediated killing of schistosomula in vitro.
    Malkin R; Flescher E; Lengy J; Keisari Y
    Immunobiology; 1987 Dec; 176(1-2):63-72. PubMed ID: 2834289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
    James SL; Lazdins JK; Hieny S; Natovitz P
    J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. III. Correlation of resistance with induction of activated larvacidal macrophages.
    James SL
    J Immunol; 1986 May; 136(10):3872-7. PubMed ID: 3084646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the interaction between macrophages and developmental stages of Schistosoma mansoni: effect of muramyl tripeptide phosphatidyl ethanolamine (MTP-PE) treatment on mice survival and the generation of schistosomulicidal macrophages.
    Seger M; Gold D; Lengy J; Pauli H; Keisari Y
    Parasite Immunol; 1992 Jul; 14(4):355-69. PubMed ID: 1437229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro killing of schistosomula of Schistosoma mansoni by BCG and C. parvum-activated macrophages.
    Mahmoud AA; Peters PA; Civil RH; Remington JS
    J Immunol; 1979 May; 122(5):1655-7. PubMed ID: 376723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The schistosomulicidal activity and the production of IL-1 and TNF-alpha by peritoneal macrophages from infected mice and their potentiation by muramyl tripeptide-phosphatidyl ethanolamine (MTP-PE) treatment.
    Seger M; Gold D; Lengy J; Pauli H; Keisari Y
    Parasite Immunol; 1993 Jun; 15(6):339-47. PubMed ID: 8361776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of macrophage activation and resistance by suppressor T lymphocytes in chronic murine Schistosoma mansoni infection.
    Olds GR; Ellner JJ
    J Immunol; 1984 Nov; 133(5):2720-4. PubMed ID: 6237154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment.
    Chaiworaporn R; Maneerat Y; Rojekittikhun W; Ramasoota P; Janecharut T; Matsuda H; Kitikoon V
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):846-52. PubMed ID: 16295535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. II. Analysis of cellular responses.
    James SL; Correa-Oliveira R; Leonard EJ
    J Immunol; 1984 Sep; 133(3):1587-93. PubMed ID: 6431002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophages as effector cells of protective immunity in murine schistosomiasis. II. Killing of newly transformed schistosomula in vitro by macrophages activated as a consequence of Schistosoma mansoni infection.
    James SL; Sher A; Lazdins JK; Meltzer MS
    J Immunol; 1982 Apr; 128(4):1535-40. PubMed ID: 7061842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B-induced resistance to Schistosoma mansoni.
    Olds GR; Stewart SJ; Ellner JJ
    J Immunol; 1981 May; 126(5):1667-70. PubMed ID: 7217661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic delivery of an adenovirus expressing EBV-derived vIL-10 in mice infected with Schistosoma mansoni or Leishmania amazonensis: controversial effects on the development of pathological parameters.
    Verwaerde C; Thiam K; Delanoye A; Fernandez-Gomez R; D'Halluin J; Auriault C
    Eur Cytokine Netw; 1999 Jun; 10(2):161-70. PubMed ID: 10400822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
    Reisser D; Jeannin JF; Martin F
    C R Seances Acad Sci III; 1982 Nov; 295(8):485-8. PubMed ID: 6819063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective vaccine-induced resistance to Schistosoma mansoni in P strain mice. III. Specificity of the associated defect in cell-mediated immunity.
    James SL; Deblois LA; Al-Zamel F; Glaven J; Langhorne J
    J Immunol; 1986 Dec; 137(12):3959-67. PubMed ID: 3097138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice.
    Van Nassauw L; Toovey S; Van Op den Bosch J; Timmermans JP; Vercruysse J
    Travel Med Infect Dis; 2008 Sep; 6(5):253-8. PubMed ID: 18760248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preactivation of macrophages in mice acutely infected with Schistosoma mansoni.
    Esparza I; Ruppel A; Mestan J; Krammer PH
    Immunobiology; 1988 May; 177(2):105-19. PubMed ID: 3136079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice with a targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansoni.
    King CL; Xianli J; Malhotra I; Liu S; Mahmoud AA; Oettgen HC
    J Immunol; 1997 Jan; 158(1):294-300. PubMed ID: 8977202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triclabendazole and its two main metabolites lack activity against Schistosoma mansoni in the mouse model.
    Keiser J; El Ela NA; El Komy E; El Lakkany N; Diab T; Chollet J; Utzinger J; Barakat R
    Am J Trop Med Hyg; 2006 Aug; 75(2):287-91. PubMed ID: 16896134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.